Machine learning-derived prognostic signature for progression-free survival in non-metastatic nasopharyngeal carcinoma.
Journal:
Head & neck
PMID:
39077955
Abstract
BACKGROUND: Early detection of high-risk nasopharyngeal carcinoma (NPC) recurrence is essential. We created a machine learning-derived prognostic signature (MLDPS) by combining three machine learning (ML) models to predict progression-free survival (PFS) in patients with non-metastatic NPC.